Multimorbidity of depression in neoplasm patients affects adherence to chemotherapy, quality of life, and treatment outcome. Describing the variations in the magnitude of depression among cancer patients helps to design evidence-based intervention based on the type and stage of neoplasm, and existence of comorbidities. This systematic review and meta-analysis aimed to determine the pooled prevalence of depression among neoplasm patients in sub-Saharan Africa.